The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): A retrospective study of 104 patients
Abstract
In addition to multiple peripheral neurofibromas, Neurofibromatosis 1 (NF1) predisposes to CNS tumours. Most of them are pilocytic astrocytomas, arise in children and are located in the optic pathways or in the brainstem. The majority are indolent, but factors predictive of poor prognosis have yet to be identified. Furthermore, the incidence and natural history of gliomas of a higher grade, arising in adults or involving other locations are largely unknown in NF1. In order to address these issues, we performed a retrospective study of 104 patients followed in seven French centres between 1982 and 2000. Inclusion criteria were a diagnosis of NF1, according to the National Institutes of Health criteria, and the presence of a CNS tumour, regardless of type, location or age of onset. The series included 88 children (age range 3 months to 17 years) and 16 adults (age range 19-52 years). The median follow-up was 5.6 years. One hundred and twenty-seven CNS tumours were observed in the 104 patients. Eighty-four (66%) were optic pathway tumours (OPT) and 43 (34%) extra-optic pathway tumours (extra-OPT) (brainstem: n = 21; other locations: n = 22). Twenty-one patients (20%) had multiple CNS tumours. OPT were symptomatic in 50 patients and extra-OPT in 19. Main clinical findings at presentation included visual loss (n = 29; 58%) and precocious puberty (n = 5; 10%) for OPT, increased intracranial pressure (n = 9; 48%) for extra-OPT. Fourteen out of the 27 symptomatic tumours with histology were pilocytic astrocytomas. The overall survival rate was 90% at 5 years (95% confidence interval 82-95%). Extra-optic location, tumour diagnosis in adulthood and symptomatic tumours were independent factors associated with shorter survival time (P < 0.05, Cox model). Radiotherapy for OPT was associated with vascular complications (ischaemic strokes) and growth hormone deficiency in 32 and 46% of patients, respectively. In conclusion, mortality is high in extra-OPT, particularly in adults, whereas OPT are only exceptionally life-threatening. Radiotherapy of OPT is associated with an important morbidity in NF1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
American Journal of Neuroradiology
(2020) · American Journal of Neuroradiology · doi:10.3174/ajnr · Cited by 2,453
Neurofibromatosis: Conference Statement
(1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520290115023 · Cited by 1,547
Pathology and genetics of tumours of the nervous system.
Kleihues, P., & Cavennee, W. (2000) · International Agency for Research on Cancer eBooks · Cited by 1,432
Gutmann, D. H. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550010065042 · Cited by 1,359
Von Recklinghausen Neurofibromatosis
Riccardi, V. M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112313052704 · Cited by 1,344
Neurofibromatosis. Conference statement, National Institute of Health development conference
Stumpf, D. A. (1988) · JAMA Neurology · Cited by 1,236
VON RECKLINGHAUSEN NEUROFIBROMATOSIS: A CLINICAL AND POPULATION STUDY IN SOUTH-EAST WALES
HUSON, S. M., HARPER, P. S., & COMPSTON, D. A. S. (1988) · Brain · doi:10.1093/brain/111.6.1355 · Cited by 686
Packer, R. J., Ater, J., Allen, J., Phillips, P., Geyer, R., Nicholson, H. S., Jakacki, R., Kurczynski, E., Needle, M., Finlay, J., et al. (1997) · Journal of Neurosurgery · doi:10.3171/jns.1997.86.5.0747 · Cited by 636
Long-Term Follow-up of von Recklinghausen Neurofibromatosis
Sørensen, S. A., Mulvihill, J. J., & Nielsen, A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604173141603 · Cited by 617
Epidemiology of neurofibromatosis type 1
Friedman, J. M. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1<1::aid-ajmg3>3.0.co;2-8 · Cited by 577
Listernick, R., Charrow, J., Greenwald, M., & Mets, M. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70122-9 · Cited by 548
Listernick, R., Louis, D. N., Packer, R. J., & Gutmann, D. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410204 · Cited by 478
Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1,728 patients
Friedman, J. M., & Birch, P. H. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970516)70:2<138::aid-ajmg7>3.0.co;2-u · Cited by 432
NF1 Gene and Neurofibromatosis 1
Rasmussen, S. A., & Friedman, J. M. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010118 · Cited by 401
von Recklinghausen Neurofibromatosis
Lewis, R. A., Gerson, L. P., Axelson, K. A., Riccardi, V. M., & Whitford, R. P. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34217-8 · Cited by 354
Sorsby, A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90662-7 · Cited by 262
Neurological complications of neurofibromatosis type 1 in adulthood
Créange, A., Zeller, J., Rostaing-Rigattieri, S., Brugières, P., Degos, J.-D., Revuz, J., & Wolkenstein, P. (1999) · Brain · doi:10.1093/brain/122.3.473 · Cited by 247
Self-citationBrainstem gliomas in adults: prognostic factors and classification
Guillamo, J.-S. (2001) · Brain · doi:10.1093/brain/124.12.2528 · Cited by 245
Self-citationIntracranial gliomas in neurofibromatosis type 1
Listernick, R., Charrow, J., & Gutmann, D. H. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1<38::aid-ajmg8>3.0.co;2-m · Cited by 176
Neurofibromatosis: Past, Present, and Future
Riccardi, V. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105023241812 · Cited by 159
The management of brainstem gliomas in patients with neurofibromatosis 1
Pollack, I. F., Shultz, B. L., & Mulvihill, J. J. (1996) · Neurology · doi:10.1212/wnl.46.6.1652 · Cited by 153
MRI findings in children with neurofibromatosis type 1: a prospective study
Es, S., North, K. N., McHugh, K., & SILVA, M. (1996) · Pediatric Radiology · doi:10.1007/bf01377205 · Cited by 144
Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children
DeBella, K., Poskitt, K. J., Szudek, J., & Friedman, J. M. (2000) · Neurology · doi:10.1212/wnl.54.8.1646 · Cited by 139
Ferner, R. E., Chaudhuri, R., Bingham, J., Cox, T. C. S., & Hughes, R. A. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.5.492 · Cited by 136
Brainstem tumors in patients with neurofibromatosis type 1
Molloy, P. T., Bilaniuk, L. T., Vaughan, S. N., Needle, M. N., Liu, G. T., Zackai, E. H., & Phillips∥, P. C. (1995) · Neurology · doi:10.1212/wnl.45.10.1897 · Cited by 123
Tao, M. L., Barnes, P. D., Billett, A. L., Leong, T. L., Shrieve, D. C., Scott, R. M., & Tarbell, N. J. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00359-3 · Cited by 111
Leroy, K., Dumas, V., Martin‐Garcia, N., Falzone, M.-C., Voisin, M. C., Wechsler, J., Revuz, J. E., Créange, A., Levy, E., Lantieri, L. A., et al. (2001) · PubMed · Cited by 105
Self-citationNF1: a prevalent cause of tumorigenesis in human cancers?
Seizinger, B. R. (1993) · Nature Genetics · doi:10.1038/ng0293-97 · Cited by 101
Deliganis, A. V., Geyer, J. R., & Berger, M. S. (1996) · Neurosurgery · doi:10.1097/00006123-199606000-00010 · Cited by 94
Magnetic Resonance Imaging Lesion Analysis in Neurofibromatosis Type 1
DiMario, F. J., & Ramsby, G. R. (1998) · Archives of Neurology · doi:10.1001/archneur.55.4.500 · Cited by 75
(2013) · Journal of Neuro-Oncology · doi:10.1007/11060.1573-7373 · Cited by 58
Neurofibromatose 1 : recommandations de prise en charge
Pinson, S., Créange, A., Barbarot, S., Stalder, J. ‐., Chaix, Y., Rodriguez, D., Sanson, M., Bernheim, A., D'Incan, M., Doz, F., et al. (2002) · Archives de Pédiatrie · doi:10.1016/s0929-693x(01)00695-9 · Cited by 47
Self-citationSpecial issues in the management of gliomas in children with neurofibromatosis 1
Pollack, I. F., & Mulvihi, J. (1996) · Journal of Neuro-Oncology · doi:10.1007/bf00250204 · Cited by 40
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Cited by
Gutmann, D. H., Ferner, R. E., Listernick, R. H., Korf, B. R., Wolters, P. L., & Johnson, K. J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.4 · Cited by 862
Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendations
Listernick, R., Ferner, R. E., Liu, G. T., & Gutmann, D. H. (2007) · Annals of Neurology · doi:10.1002/ana.21107 · Cited by 576
Presentation of childhood CNS tumours: a systematic review and meta-analysis
Wilne, S., Collier, J., Kennedy, C., Koller, K., Grundy, R., & Walker, D. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70207-3 · Cited by 404
Sharif, S., Ferner, R., Birch, J. M., Gillespie, J. E., Gattamaneni, H. R., Baser, M. E., & Evans, D. G. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8349 · Cited by 377
Evans, D. G. R., Birch, J. M., Ramsden, R. T., Sharif, S., & Baser, M. E. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.036319 · Cited by 301
Metadata
- Authors
- Guillamo, J.-S., Creange, A., Kalifa, C., Grill, J., Rodriguez, D., Doz, F., Barbarot, S., Zerah, M., Sanson, M., Bastuji-Garin, S., Wolkenstein, P., & France, F. T. R. N.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01-01
- Volume
- 126
- Issue
- 1
- Pages
- 152-160
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2034029713
- Cited by
- 295
- References
- 37
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.